Glycogen synthase kinase-3: a potential preventive target for prostate cancer management. [electronic resource]
- Urologic oncology Nov 2015
- 456-63 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
1873-2496
10.1016/j.urolonc.2015.05.006 doi
Antineoplastic Agents--pharmacology Disease Management Glycogen Synthase Kinase 3--antagonists & inhibitors Glycogen Synthase Kinase 3 beta Humans Male Prostatic Neoplasms--prevention & control Signal Transduction--drug effects